Effect of Alcohol on Brain Development by Patel, Farhin & Mandal, Palash
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 2
Effect of Alcohol on Brain Development
Farhin Patel and Palash Mandal
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.73693
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
Effect f lc l  rai  evel e t
r i   t l  l s   l
Additional infor ation is available at the end of the chapter
Abstract
In the world, 3.3 million deaths occur every year due to harmful use of alcohol; this 
represents 5.9% of all deaths. Ethanol metabolites’ production and their post-translation 
modification are one of the proposed mechanisms that lead to neuronal toxicity. The 
projected neurochemical changes in chronic alcohol drinkers may be due to an imbalance 
between excitatory and inhibitory neurotransmitters. Interaction of alcohol with GABA 
and glutamate receptors (NMDA and AMPA) resulted in diverse adaptive changes in 
gene expression through neuronal pathways leading to alcohol toxicity. Alcohol con-
sumption in an individual leads to biochemical changes that are correlated with com-
plex inflammatory signaling pathways such as phosphorylation of proteins, synthesis 
of nitric oxide (NO), NF-kappaB and MAP kinase pathways in certain regions of the 
brain. Ethanol exposure activates neurons and microglial cells that lead to release of neu-
roimmune factors like high-mobility group box 1 (HMGB1), toll-like receptor 4 (TLR4) 
and certain cytokines involved in immune responses leading to neuroimmune signaling 
in the brain. Epigenetic modification of DNA and histones may lead to neuronal gene 
expression, thus regulating ethanol toxicity. Researchers attempt to modulate therapies 
that can help to foil alcohol toxicity and support the development of original neuronal 
cells that have been injured or degenerated by alcohol exposure.
Keywords: brain, alcohol, epigenetic, alcohol-responsive genes (ARGs), immune 
responses
1. Introduction
1.1. How alcohol is absorbed into the body?
Some people drink socially and do not get addicted while others do. The ground behind the 
alcohol drinking is related to psychological, physiological, genetics and social factors.
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When people consume alcohol, about 20% is absorbed in the stomach and almost 80% is 
absorbed in the small intestine. Alcohol absorption is related to the two main factors:
a. concentration of alcohol and
b. heavy meal consumption before drinking. An empty stomach will fasten the alcohol 
absorption.
Absorbed alcohol enters the blood stream and is carried all through the body. Upon reaching 
the body, simultaneously the body works to eliminate it. The 10% of alcohol is removed by 
the kidneys (urine) and lungs (breath). Left-out alcohol is oxidized by the liver, converting 
alcohol into acetaldehyde first and then further converted to acetic acid.
1.2. Alcohol metabolism and distribution
Alcohol is absorbed in the stomach and intestines through the blood stream and crosses the 
blood-brain barrier (BBB) after consumption. Alcohol is metabolized through the mitochon-
drial cytochrome P450 (CYP2E1) and catalase in the liver or the brain. In the brain, alcohol 
metabolism by CYP2E1 produces acetaldehyde and alcohol is considered to be the only source 
of acetaldehyde. The rest of the acetaldehyde may go through the brain by an enzyme called 
alcohol dehydrogenase (ADH) which is found in the liver and helps in conversion of alcohol to 
acetaldehyde. Target of alcohol is considered to be ADH. Alcohol binds through its hydroxyl 
(─OH) group and zinc atom on ADH [1]. Disulfiram (antabuse), one of the first approved 
treatments for alcoholism, showed its mechanism by inhibiting the ADH enzyme. When taken 
regularly, disulfiram decreases the drinking capacity because of the aversive effects [2].
2. Alcohol and the brain
2.1. How does alcohol act at the neurological level?
Brain chemistry is affected by alcohol through alteration of neurotransmitters. Neurotrans-
mitters are chemical messengers that send out the signals all through the body and control 
thought processes, behavior and sensation processes. Neurotransmitters are either excit-
atory (excite brain electrical motion) or inhibitory (decrease brain electrical motion). Alcohol 
increases the effects of the inhibitory neurotransmitter GABA in the brain. GABA causes the 
lethargic movements and garbled speech that often occur in alcoholics. At the same time, 
alcohol inhibits the excitatory neurotransmitter glutamate, which results in a suppression 
of a similar type of physiological slowdown. In addition, alcohol also increases the amount 
of chemical dopamine in the brain center, which creates the feeling of pleasure after drink-
ing alcohol. Just after a few drinks, the physical effects of alcohol become perceptible. These 
effects are linked to blood alcohol concentration (BAC) (Table 1). The level of BAC rises when 
the body takes up alcohol faster than it can release it.
In the brain, various centers have been affected due to alcohol, both upper and lower order. 
As the BAC increases, more centers of the brain are affected (Figure 1) [3]. The order in which 
brain centers are affected by alcohol consumption is as follows:
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1. cerebral cortex
2. limbic system
3. cerebellum
4. hypothalamus and pituitary gland
5. medulla (brain stem)
2.1.1. Long-term effect of alcohol on the brain
Continuous or excessive drinking can lead to undeviating injury, causing the brain to shrivel. 
This leads to deficiency in fibers that transfers the information between neuronal cells. 
Excessive alcohol leads to a condition called Wernicke-Korsakoff syndrome (deficiency of 
thiamine) [4]. Alcohol interference leads to this deficiency, as it blocks the way of vitamin B 
absorption in the body. Symptoms of the Wernicke-Korsakoff syndrome are mental perplex-
ity, lack of fine movements, memory and learning problems.
Euphoria 
(BAC = 0.03–
0.12%)
Excitement 
(BAC = 0.09–0.25%)
Confusion 
(BAC = 0.18–0.30%)
Stupor 
(BAC = 0.25–0.4%)
Coma 
(BAC = 0.35–
0.50%)
Death (BAC 
more than 
0.50%)
They become 
more self-
assured or 
brave.
They become lethargic. They become 
woozy and may 
walk unsteadily.
They can barely 
move at all.
They are 
unconscious.
The person 
usually stops 
breathing and 
dies.
Their 
awareness 
period 
shortens.
They have a problem 
in understanding or 
recalling things (even 
recent events).
They may be 
highly emotional, 
destructive, 
reserved or overly 
loving.
They may lapse 
in and out of 
consciousness.
Their reflexes 
are depressed.
They may look 
flushed (red).
They do not respond to 
situations as quickly
They cannot 
observe clearly.
They cannot 
respond to stimuli.
They feel cold.
Their 
conclusive 
power is not as 
good.
Their body movements 
are uncoordinated.
They are drowsy. They cannot stand 
or walk.
Their breathing 
is slower and 
shallower.
They have 
trouble 
with fine 
movements, 
such as 
writing.
They start to lose their 
sense of balance easily.
They have garbled 
speech.
They may vomit. Their heart rate 
may slow.
Their vision becomes 
dim.
They have clumsy 
movements.
They may die.
They may have 
problems in sensing 
things (hearing, tasting, 
emotion, etc.).
They may not 
feel tenderness as 
readily as a sober 
person.
Table 1. The effect of alcohol exposure on the brain.
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Heavy or continuous consumption of alcohol can lead to the liver injury. The liver is the chief 
organ responsible for converting alcohol into nontoxic byproducts and taking them out of the 
body. Excessive alcohol consumption leads to prolonged liver dysfunction which may also 
harm the brain, leading to a severe fatal brain disorder known as hepatic encephalopathy [5]. 
Studies have confirmed that at least two toxic substances, ammonia and manganese, play an 
important role in the progress of hepatic encephalopathy.
Treatment—Strategies that have been used to treat or prevent the development of hepatic 
encephalopathy are as follows:
1. L-ornithine L-aspartate: it lowers the concentration of blood ammonia
2. Artificial livers: it clears patients’ harmful toxins present in the blood [6]
3. Liver transplantation [7]
2.1.2. Alcohol and the developing brain
Alcohol consumption during pregnancy can lead to changes in the physical, learning and 
behavioral effects in the developing brain and it is known as fetal alcohol syndrome (FAS) 
[8].The brains of these people may have less size (i.e., microencephaly) and also a small 
amount of brain cells (i.e., neurons) that function accurately resulting in long-lasting prob-
lems in learning and behavior.
Treatment: Researchers are looking forward to treat or prevent brain damage, such as associ-
ated with FAS.
Figure 1. Effect of alcohol on various brain centers.
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1. In-vivo studies yielded a result showing antioxidant therapy and vitamin E which is used 
for treating FAS.
2. Treatment with l-octanol (paradoxically an alcohol itself) on developing mouse embryos 
significantly reduced the rigorousness of alcohol’s effects [8].
3. NAP and SAL have the same property as octanol. They both help in protecting nerve cells 
against a variety of toxins [9].
4. A compound called MK–801 that blocks glutamate that helps with alcohol withdrawal [10].
2.2. Alcohol-induced neurotransmitters and its effect on the neurons
2.2.1. Glutamate
Glutamate receptors include metabotropic glutamate receptor (mGlu), N-methyl-D-aspartic 
acid (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). 
Glutamate exhibits its action on binding to these receptors, resulting in the activation of 
G-proteins which further leads to amplification of phospholipase C, diacylglycerol (IP3DAG) 
and calcium-dependent protein kinases [11].
During alcohol drinking, there is a release of excessive glutamate leading to neuronal cell 
death. This occurs through two pathways:
1. Activation of glutamate receptors causes toxicity [12], resulting into Ca+2 ion influx, Na+ 
influx, nitric oxide (NO) generation and depolarization of mitochondria. This will lead to 
untenable elevations in ATP, mitochondrial collapse, dendritic beading and depolymeriza-
tion of microtubule [13].
2. Oxidative toxicity to glutamate [14].
A study has been carried out on 13 abstinent young alcoholics showing a major increase in 
glutamate to creatine ratio by proton magnetic resonance spectroscopy and magnetic reso-
nance imaging [15]. Furthermore, an alteration in glutamate is linked to altered short memory 
loss. Immediate administration of alcohol (acute dose) prior to the microdialysis experiment 
would end up into an increased glutamate release. Earlier studies showed that administra-
tion of either 2 or 3 g/kg ethanol to immature rats elicits a decrease or no modification in the 
release of glutamate into the N-acetyl cysteine (NAC) [16]. Researchers showed that there is a 
genetic component that probably contributes to the brain injury occurring in “binge drinking” 
alcoholics [17]. In binge drinking, alcohol models, there are no reports of increased NMDA 
receptors [18]. In one study, “binge- drinking” individuals with compensated alcoholic cir-
rhosis, dosing 80 g of ethanol, showed a transient increase in serum nitrates and nitrite result-
ing in an increase in NO production in certain tissues (liver and brain) [19]. During the period 
of chronic alcohol toxicity, basal concentration of glutamate seems to be normal in various 
regions of the brain though blood alcohol levels are high as 2 g/l [20].
During chronic alcohol consumption, NMDA receptor (NMDAR1 and NMDAR2B) levels 
seem to be increasing in numbers and decreasing in sensitivity [21] in the nucleus [22], the 
striatum [23] and the hippocampus [20].
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2.2.2. Gamma-amino-butyric acid
It is a chief inhibitory neurotransmitter. GABA binds to GABAA receptors, resulting in hyper-polarization of the cell membrane and inhibition of neural activity. Increased GABA release 
upon alcohol administration results due to inhibiting its degradation [24]. Alcohol intoxicity 
and alcohol’s anti-anxiety reduce due to decrease in GABAA receptor activity. Chronic alcohol exposure decreases extrasynaptic GABA-mediated tonic current recorded from neurons in 
the hippocampus and cortex [25], and this corresponds to a decrease in extrasynaptic GABAA receptors containing the d subunit in hippocampus [26]. Benzodiazepines (the positive allo-
steric modulator of GABAA) are considered to be a standard for treating alcohol detoxifica-tion owing to their anticonvulsant and anxiolytic pharmacological profile. Improper alcohol 
interactions have shown some concern about their abuse and dependence responsibility. 
Therefore, researchers are trying to find out potential anticonvulsant agents as alternatives, 
that is, gabapentin and topiramate [27, 28].
2.2.3. Dopamine
Transmission of dopamine is linked via two groups of G-protein-linked receptors: D1-like 
(D1 and D5 receptors) and D2-like (D2, D3 and D4 receptors). These receptors are classified 
on the basis of adenylatecyclase activity (stimulation or inhibition). Dopamine plays a central 
role in mediating alcohol compensation through mesocortical and mesolimbic pathways [29]. 
During chronic alcohol consumption, the release of dopamine depends on the large amount 
of the alcohol consumption, which gives pleasurable effect of alcohol intake. Reduction in 
dopamine release is observed during alcohol withdrawal. This ultimately reduces noticeable 
neuronal cells, leading to dysphoria and depression as a major part in the motivational and 
behavioral changes [30]. Chronic alcohol drinking has been reported to produce constant neu-
rological changes in transmission of dopamine within the mesoaccumbens reward circuitry, 
including increased basal extracellular levels of dopamine in the NAC [31], increased firing 
rate in the ventral tegmental area (VTA) dopamine neurons [32] and changes in the function 
of dopamine receptor [33]. In comparison, withdrawal from chronic alcohol drinking due to 
increased dopamine uptake levels resulted in decreased VTA dopamine neuronal activity 
[34], and reduced basal levels of dopamine in the ventral and dorsal subregions of the stria-
tum, possibly due to enhanced dopamine uptake [35]. The aripiprazole (D2 dopamine recep-
tor agonist) has shown some effectiveness in treating dependence of alcohol [36].
2.2.4. Serotonin
Serotonin exerts its known role in regulating various behaviors (e.g., feeding, sleep/arousal, 
aggression), mood and emotional behavior [37] via several metabotropic (5-HT1 and 5-HT2 
subtypes) and ionotropic (5-HT3) receptors throughout the brain depending on the consump-
tion of alcohol [38]. Alcohol elevates serotonin release in the central nervous system (CNS) 
affecting emotion, temper and thoughts. The 5-HT3 receptor function is altered by ethanol 
consumption through its actions on receptor proteins [39]. Chronic alcohol exposure reduces 
serotonin levels in several brain regions [40]. Researchers have focused on the treatment for 
alcohol dependence and comorbid depression [41], post-stress disorder [42] and anxiety [43]. 
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Inhibition of serotonin reuptake was done through fluoxetine. The milnacipran blocks both 
serotonin and norepinephrine reuptake. Both fluoxetine and milnacipran are found to be 
effective in reducing alcohol consumption in the rats model [44]. Consumption of alcohol 
(5%) every third day for 18 days leads to disturbance in serotonin function within the nucleus 
accumbens [45] (Tables 2 and 3).
2.3. Biochemical changes associated with alcohol intoxicity
Alcohol consumption in an individual leads to biochemical changes that are correlated with 
complex signaling pathways such as phosphorylation of proteins, synthesis of nitric oxide 
(NO), NFκBand MAP kinase pathways in certain regions of the brain [48].
2.3.1. Generation of free radicals
Alcohol-induced brain damage may occur due to generation of free radicals [49] by acetalde-
hyde intoxicity [50] or microsomal ethanol oxidizing system (MEOS) [51]. This can be mini-
mized, if there would be a reduction in glutathione (cytoprotection) in the specific regions of 
the brain which is affected.
2.3.2. Changes in phosphorylation
Cell signaling events depend on phosphorylation of proteins (phosphorylation: protein kinase and 
dephosphorylation: protein phosphatases). During intoxication in hippocampal dentate gyrus, 
Neurotransmitters Effect of alcohol in the brain References
Glutamate Inhibits glutamate receptor function [13, 14]
GABA Potentiates GABA receptor function [24]
Dopamine Increases dopamine concentration [31]
Serotonin Decreases serotonin neurotransmission [39]
Table 2. Neurotransmitters and its effect on the brain system.
Neurotransmitters Drug found to reduce alcohol consumption References
Glutamate Amitriptyline [46]
GABA Benzodiazepines (positive allosteric modulator of GABAA) [27, 28]
Gabapentin (anticonvulsant)
Topiramate (anticonvulsant)
Dopamine Aripiprazole (D2 dopamine receptor agonist) [36]
Serotonin Fluoxetine and milnacipran [44]
Dansetron (5-HT3 receptor antagonist) [47]
Table 3. Neurotransmitters-associated drug to reduce alcohol toxicity in the brain.
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the total phosphorylated c-AMP response element-binding protein (CREB) immunoreactivity is 
reduced in both chronic or binge drinking. In rat cerebellum, the dose of 3 g/kg alcohol (acute) 
shows an increase in a phosphorylated form of CREB. Research showed that protein phosphatase 
inhibitor (DARPP-32), when it undergoes phosphorylation changes, plays a crucial role in reduc-
ing ethanol inhibition of NMDA receptors [52].
2.3.3. Transcription factors
They are the first signaling proteins which are regulated through sensitive cysteine residues, 
which need to be reduced to its function. Earlier studies showed that production of reactive 
oxygen species (ROS) is responsible for the activation of NFκB [53]. Later in vitro studies 
showed that exogenous hydrogen peroxide is responsible for NFκB activation [54]. In the 
cortex, one study reported activation of NFκB in chronically alcoholized rats [55]. It was quite 
clear that NFκB was down-regulated in comparison to acute alcohol drinking. One study 
showed no NFκB activation in binge alcohol drinking models, when given anti-oxidants 
(furosemide and butylatedhydroxytoluene) to prevent neuronal degeneration [56].
2.4. Epigenetic mechanism
It is an efficient mechanism for gene regulation by altering the packaging of DNA within 
chromatin through interactions with histones. CREB requires phosphorylation to initiate tran-
scription of pro-survival neuronal factors (Figure 2). A study revealed an increase in CREB 
(a regulator for plasticity of neurons), increase in H3-H4 (a central histone tetramer) acetyla-
tion and inhibition of HDAC (histone deacetylases) activity in a rat amygdala when given an 
acute dose of ethanol for 15 days. A trichostatin (HDAC inhibitor) was used to treat the rats, 
resulting in deacetylation of H3-H4, CREB inhibition, reduced NPY expression and HDAC 
activation in the rat amygdala [57].
Figure 2. Epigenetic modifications associated with alcoholism.
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2.5. Genome profiling of alcohol-responsive genes
With recent technologies like direct sequencing and gene microarray, studying individual 
genes along with entire genome of an organism has been made possible.
2.5.1. Microarray study
First genome microarray studies were performed in post-mortem alcoholics’ human brain; 
results revealed that myelin related genes expressed in oligodendrites (from frontal cortex) 
showed downregulation in the brains of human alcoholics compared with brains from con-
trol individuals [58], suggesting neuronal dysfunction. In the prefrontal cortex area of the 
brain, there were 54 genes which were upregulated and those belong to the class of heat 
shock protein, including HSP70–2, CRYAB, HSP27–1 and HSP40–1 in alcoholic abusive indi-
viduals [59]. An old study revealed that 100 mM ethanol (2 days) given to NG108–15 hybrid 
cell line determined that a number of genes were induced by heat shock and a few were 
induced by ethanol only. Heat-shock cognate proteins Hsc 70 and Hsc 110 were recognized 
as ethanol-inducible genes [60]. When C. elegans was given a high dose of ethanol, it showed 
activation of glr-2, a gene that encodes a subunit of the AMPA glutamate receptor subunit 
(homologous to mammalian GluR2) within 15 min [61]. Cultured cortical neurons given 
75 mM of ethanol for 5 days showed increased levels of gene expression of Hsp84, Hspa8 and 
Hsp70 [62]. In a whole brain, when C57BL/6J and DBA/2J mouse strains were given acute 
doses of different ethanol preferences, they revealed downregulation of Erbb3, Mobp and 
Nkx2-2 (myelin-related genes) [63].
The researcher performed a genomic level along with a microarray experiment on neu-
rons of mouse corticals given 60 mM ethanol or heat treatment at 42°C. Microarray results 
showed upregulation of a large number of genes by ethanol and heat shock [64]. Among 
the pool of genes, there were nine genes which showed greater than 50% stimulation. It 
includes.
• gene-encoding proteins involved in synaptic neurotransmission: Syt1 and Spnb2;
• gene-encoding proteins involved in synaptic plasticity and synaptic formation: glycopro-
tein m6a (Gpm6a), neurogranin (Nrgn) and cadherin 13 (Cdh13);
• and gene-encoding proteins involved in microtubule assembly, microtubule-associated 
protein 1B (Mtap1b) [64].
2.5.2. Analysis of quantitative trait loci
A quantitative trait loci (QTL) refers to the trait that varies in degree and can be attributed to 
the interactions between two or more genes and their environment. Possible QTLs have been 
identified through microarray studies for alcohol uptake. An analysis is done across inbred 
mouse strains identified a group of genes for alcohol preference QTL on chromosome 9. These 
genes include Arhgef12, Carm1, Cryab (heat shock protein), Cox5a, Dlat, Fxyd6, Limd1, Nicn1, 
Nmnat3, Pknox2, Rbp1, Sc5d, Scn4b, Tcf12, Vps11 and Zfp291 [65].
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2.6. Activation of multiple neuroimmune genes in human alcoholic brains
In human brain-slice cultures, multiple ethanol-induced cytokines are released. Among all, 
monocyte chemotactic protein-1 (MCP-1) showed increased levels in the amygdala, nucleus 
accumbens, VAT and hippocampus [66]. In alcoholic brains, elevated levels of TLR 2, TLR3, 
TLR4 and HMGB1 (high-mobility group box 1) were found in the orbital frontal cortex (OTC) 
[67]. Release of HMGB1 leads to disruption of synaptic plasticity which causes hyperexcitabil-
ity of neurotransmitters due to ethanol exposure. There is an increased level of IL-1β inflam-
matory marker in an alcoholic brain (hippocampus) causing neuro-degeneration [68]. RAGE 
(HMGB1 receptor) has shown an increased level in an alcoholic brain [69].
2.6.1. Role of microglia
Exposure to alcohol causes activation of microglia along with the proinflammatory cytokines, 
leading to neuronal inflammation and toxicity [70]. Alcohol exposure causes accumulation of 
microglia in the brain which occurs through activation of TLRs leading to increased HMGB1 
expression [71]. Alcohol-induced neuronal apoptosis leads to stimulation of the transcription fac-
tor AP-1 and release of IL-1β, IL-6 and transforming growth factor β (TGF-β1) [71]. An in vitro 
study revealed that microglial TNF-α production plays an important role in neuronal toxicity [72]. 
Neuronal cell death occurred due to chronic alcohol exposure which leads to upregulation of the 
NF-κB expression, which in turn leads to release of TNF-α resulting in neuronal apoptosis [73].
In vivo studies in the cortical and hippocampus region of the brain showed increased levels 
of NADPH oxidase, superoxide and microglial activation, which is correlated with alcohol-
induced ROS production [74]. In vitro studies revealed that upon alcohol exposure, microglia-
conditioned cells showed increased ROS production and induced oxidative stress in cultured 
hypothalamic neuronal cells; this leads to neuronal apoptosis [75]. Alcohol-induced elevation 
of TGF-β1 levels in neuronal cells is accompanied by a host of molecular and chemical changes 
such as increase in E2F1 protein expression, mitochondrial proapoptotic proteins bak, bad and 
bcl-xs and E2F1 protein expression and simultaneously decrease in cyclin D1, cyclin-dependent 
kinase-4 expression and antiapoptotic protein bcl-2 leading to neuronal apoptosis [76] (Figure 3).
2.7. The brain and immune responses
The interface between the brain and the immune system is bidirectional. Recent findings have 
revealed that alcohol causes the release of HMGB1 in the gut, which in turn activates TLR4 
Figure 3. Alcohol-induced elevation of TGF-β1 levels in neuronal cells is accompanied by a host of molecular and 
chemical changes related to cell death.
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resulting in an increased gut permeability. As a result, there is activation of proinflammatory 
cytokines in the liver, which leads to induction of TNF-α and other cytokines in the blood. 
Researchers found that LPS induced increases in serum TNF-α as well as proinflammatory 
cytokines, leading to induction of the gene in the brain [77]. This proinflammatory cytokines 
in the blood are then transported across the blood–brain barrier (BBB) by their receptors [78]. 
For example, 2 to 3 g/kg ethanol when administered into the stomach results in the activa-
tion of innate immune response in the gut [79]. This damages the tight junction present in 
the gut resulting in an opening of the sites where gut bacteria and their endotoxins (LPS) can 
easily enter the blood stream leading to the liver, where they can activate proinflammatory 
cytokines (Figure 4). Increased proinflammatory  cytokines responses, which affects  the brain 
through TNF-α and other cytokines [80]. The brain response to the proinflammatory cytokine 
MCP-1 is quite longer than that found in the liver and blood [81]. An in vivo study showed 
an increased LPS induction of proinflammatory cytokines (TNF-α, IL-1β and MCP-1) only in 
the brain but not in the liver and blood after ten daily doses of alcohol [81]. In the liver, the 
researcher suggested that the anti-inflammatory cytokine (IL-10) inhibits NF-κB which was 
increased after 1 week of ethanol treatment but decreased in the brain [81]. After 10 days of 
ethanol (5g/kg/day) administration to mice model, this study showed sensitization to TLR3 
agonist Poly:IC which induces proinflammatory cytokines in the brain for 24 hours  [74].
3. Conclusion(s)
Alcohol is an anxiolytic and soothing drug. Chronic alcohol consumption leads to deter-
mined molecular and cellular modification in the brain system. It is comprehensible that 
GABA and glutamate neurotransmitters play a crucial role in alcohol toxicity, neuronal toxic-
ity and neuronal cell death. Ethanol exposure triggers the activation of various gene expres-
sions involved in apoptosis, in oxidative stress and in the cell cycle. Upregulation of genes 
by ethanol includes heat shock proteins and proteins related to synaptic neurotransmission, 
Figure 4. Alcohol influences neuroimmune signaling via its effects on the gut.
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synaptic plasticity and synaptic formation. Downregulation of genes by ethanol includes pro-
tein synthesis, myelination and the ubiquitin-proteasome pathway. Chronic ethanol exposure 
increases HMGB1–TLR4 and NF-κB signaling which leads to improved NF-κB target genes’ 
expression. This results in determining neuroimmune responses to ethanol toxicity that 
releases HMGB1 or directly stimulates TLR and/or NMDA receptors. An epigenetic mecha-
nism will show potential towards drug dependence by changing the DNA protein structure. 
Microglial cells will arbitrate the effect of alcohol toxicity on neurogenesis. The progression 
towards the neurobiologic techniques including micro array, QTL and proteomics will pro-
vide some anticipation for researching the molecular and cellular mechanisms that act as a 
keystone for the understanding of neuronal toxicity and enlightening new therapeutic gene 
targets for this public health burden.
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